Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 355741 - 355760 out of 498429 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Poland | (R03AK07) formoterol and budesonide | DuoResp Spiromax, proszek do inhalacji, 160+4,5 µg | 1 inhalator (120 dawek), (160 mcg + 4,5 mcg)/dawkę inh. , 1 inhalator 120 dawek | Retail price with vat |
$0-0 |
$0-0 |
Pulmonary Disease, Chronic Obstructive;Asthma | TevaPharmaB.V. |
| Poland | (R03AK07) formoterol and budesonide | DuoResp Spiromax, proszek do inhalacji, 320+9 µg | 1 inhalator (60 dawek), (320 mcg + 9 mcg)/dawkę inh. , 1 inhalator 60 dawek | Retail price with vat |
$0-0 |
$0-0 |
Pulmonary Disease, Chronic Obstructive;Asthma | TevaPharmaB.V. |
| Poland | (R03AK07) formoterol and budesonide | Symbicort, aerozol inhalacyjny, zawiesina, 160+4,5 µg/dawkę inhalacyjną | 1 inh. po 120 daw., (160 mcg + 4,5 mcg)/dawkę inh. , 1 inhalator 120 dawek | Retail price with vat |
$0-0 |
$0-0 |
n/a | AstraZenecaAB |
| Poland | (R03AK08) formoterol and beclometasone | Fostex Nexthaler, proszek do inhalacji, podzielony, 100+6 µg/dawkę | 1 inh.po 180 daw., (100 mcg + 6 mcg)/dawkę inh. , 1 inhalator 180 dawek | Retail price with vat |
$0-0 |
$0-0 |
n/a | ChiesiFarmaceuticiS.p.A. |
| Poland | (R03AK08) formoterol and beclometasone | Fostex Nexthaler, proszek do inhalacji, podzielony, 100+6 µg/dawkę | 2 inh.po 180 daw., (100 mcg + 6 mcg)/dawkę inh. , 2 inhalatory 180 dawek | Retail price with vat |
$0-0 |
$0-0 |
n/a | ChiesiFarmaceuticiS.p.A. |
| Poland | (R03AK08) formoterol and beclometasone | Fostex, aerozol inhalacyjny, roztwór, 100+6 µg/dawkę | 1 poj.po 180 daw., (100 mcg + 6 mcg)/dawkę , 1 poj. 180 dawek | Retail price with vat |
$0-0 |
$0-0 |
n/a | ChiesiFarmaceuticiS.p.A. |
| Poland | (R03AK08) formoterol and beclometasone | Airiam, aerozol inhalacyjny, roztwór, 100+6 µg/dawkę | 1 poj.po 120 daw., (100 mcg + 6 mcg)/dawkę odmierzoną , 1 poj. 120 dawek | Retail price with vat |
$0-0 |
$0-0 |
n/a | Zentiva,k.s. |
| Poland | (R03AK08) formoterol and beclometasone | Formodual, aerozol inhalacyjny, roztwór, 100+6 µg/dawkę | 1 poj.po 180 daw., (100 mcg + 6 mcg)/dawkę inh. , 1 poj. 180 dawek | Retail price with vat |
$0-0 |
$0-0 |
n/a | ChiesiFarmaceuticiS.p.A. |
| Poland | (R03AK08) formoterol and beclometasone | Formodual, aerozol inhalacyjny, roztwór, 200+6 µg/dawkę | 1 poj.po 180 daw., (200 mcg + 6 mcg)/dawkę , 1 poj. 180 dawek | Retail price with vat |
$0-0 |
$0-0 |
n/a | ChiesiFarmaceuticiS.p.A. |
| Poland | (R03AK08) formoterol and beclometasone | Fostex, aerozol inhalacyjny, roztwór, 200+6 µg/dawkę | 1 poj.po 180 daw., (200 mcg + 6 mcg)/dawkę inh. , 1 poj. 180 dawek | Retail price with vat |
$0-0 |
$0-0 |
n/a | ChiesiFarmaceuticiS.p.A. |
| Poland | (R03AK14) indacaterol and mometasone | Atectura Breezhaler, proszek do inhalacji w kaps. tw., 125+127,5 µg | 30 szt., 125 mcg + 127,5 mcg , 1 inhalator | Retail price with vat |
$0-0 |
$0-0 |
Asthma | NovartisEuropharmLimited |
| Poland | (R03AK14) indacaterol and mometasone | Atectura Breezhaler, proszek do inhalacji w kaps. tw., 125+260 µg | 30 szt., 125 mcg + 260 mcg , 1 inhalator | Retail price with vat |
$0-0 |
$0-0 |
Asthma | NovartisEuropharmLimited |
| Poland | (R03AK14) indacaterol and mometasone | Atectura Breezhaler, proszek do inhalacji w kaps. tw., 125+62,5 µg | 30 szt., 125 mcg + 62,5 mcg , 1 inhalator | Retail price with vat |
$0-0 |
$0-0 |
Asthma | NovartisEuropharmLimited |
| Poland | (R03AL01) fenoterol and ipratropium bromide | Berodual, roztwór do nebulizacji, 0,5+0,25 mg/ml | 20 ml, (0,5 mg + 0,25 mg)/ml , 1 butelka 20 ml | Retail price with vat |
$0-0 |
$0-0 |
n/a | BoehringerIngelheimInternationalGmbH |
| Poland | (R03AL03) vilanterol and umeclidinium bromide | Anoro Ellipta, proszek do inhalacji, podzielony, 55+22 µg | 1 inhalator po 30 dawek, 55 mcg + 22 mcg , 1 inhalator 30 dawek | Retail price with vat |
$0-0 |
$0-0 |
Pulmonary Disease, Chronic Obstructive | GlaxoSmithKline(Ireland)Limited |
| Poland | (R03AL04) indacaterol and glycopyrronium bromide | Ultibro Breezhaler, proszek do inhalacji w kaps. twardej, 85+43 µg | 30 szt. + inhal., 85 mcg + 43 mcg , 1 inhalator | Retail price with vat |
$0-0 |
$0-0 |
Pulmonary Disease, Chronic Obstructive | NovartisEuropharmLimited |
| Poland | (R03AL06) olodaterol and tiotropium bromide | Spiolto Respimat, roztwór do inhalacji, 2,5+2,5 µg | 1 wkład 30 dawek + 1 inh., 2,5 mcg + 2,5 mcg , 1 inhalator Respimat | Retail price with vat |
$0-0 |
$0-0 |
n/a | BoehringerIngelheimInternationalGmbH |
| Poland | (R03AL08) vilanterol, umeclidinium bromide and fluticasone furoate | Trelegy Ellipta, proszek do inhalacji, podzielony, 92+55+22 µg/dawkę inhalacyjną | 1 inhalator 30 dawek, (92 mcg + 55 mcg + 22 mcg)/dawkę inh. , 1 inhalator 30 dawek | Retail price with vat |
$0-0 |
$0-0 |
Pulmonary Disease, Chronic Obstructive | GlaxoSmithKlineTradingServicesLimited |
| Poland | (R03AL09) formoterol, glycopyrronium bromide and beclometasone | Trimbow, aerozol inh., roztwór, 87+5+9 µg/dawkę inhalacyjną | 1 poj. a 180 daw., 87 mcg + 5 mcg + 9 mcg , 1 poj. 180 dawek | Retail price with vat |
$0-0 |
$0-0 |
Pulmonary Disease, Chronic Obstructive | ChiesiFarmaceuticiS.p.A. |
| Poland | (R03AL12) indacaterol, glycopyrronium bromide and mometasone | Enerzair Breezhaler, proszek do inhalacji w kaps. tw., 114+46+136 µg | 30 szt., 114 mcg + 46 mcg + 136 mcg , 1 inhalator | Retail price with vat |
$0-0 |
$0-0 |
Asthma | NovartisEuropharmLimited |
Pages
